53 results
Page 2 of 3
8-K
EX-99.1
5mc1zowtx
31 Mar 22
Vivos Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update
5:13pm
S-3
EX-1.2
tgu5 qpao
7 Feb 22
Shelf registration
9:33am
S-3
p92v4070bxh0qb7l6 by
7 Feb 22
Shelf registration
9:33am
8-K
EX-99.1
fp7 mpcntc3v31i
15 Nov 21
Vivos Therapeutics Reports Third Quarter 2021 Financial Results
4:15pm
8-K
EX-99.1
5poqqufk
12 Aug 21
Vivos Therapeutics Reports Second Quarter 2021 Financial Results and Operational Update
4:15pm
424B4
8onvd
19 May 21
Prospectus supplement with pricing info
5:30pm
8-K
EX-99.1
ac0713 m51
17 May 21
Vivos Therapeutics Reports First Quarter 2021 Financial Results and Operational Update
4:15pm
10-Q
tra vkj6r6wff5ik
17 May 21
Quarterly report
4:10pm
8-K
EX-1.1
m6zvkae
12 May 21
Vivos Therapeutics Announces Closing of Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
5:21pm
424B4
lboy9
10 May 21
Prospectus supplement with pricing info
5:06pm
8-K
EX-99.1
itr41qtp7457t0lqj zg
25 Mar 21
Vivos Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Update
4:15pm
10-K
qkd00fmghyy4
25 Mar 21
Annual report
4:15pm
8-K
EX-1.1
cpwks0e623vpu5 qn5c
15 Dec 20
Vivos Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
5:05pm